World Organoid Research Day 2026 (WORD+)

With a BSc and MSc degree in Medical Biotechnology from Berlin, Germany, Christine began her career as a Scientist specializing in 3D in vitro cell culture and organ-on-chip systems. Transitioning into Business Development in 2020, she has since focused on driving collaborations betweem CROs and Industry for early drug discovery. Currently serving as the Business Development Manager for Nordics & UK at InSphero AG since August 2023, Christine is passionate about advancing preclinical 3D cell culture solutions and Multi-Organ-Chips for drug safety and efficacy testing. Her work is dedicated to improving the drug development processes, fostering innovation, and reducing reliance on animal testing to enhance faster development of new treatment options for patients.